Bio Green Med Solution Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2024	FY 2024	FY 2024	FY 2023
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-0.09	-11.21	-0.19	-22.56	-21.2
Depreciation & Amortization	0	0.01	0.02	0.03	0.03
Stock-Based Compensation	-	0.59	-	1.47	1.51
Other Adjustments	0.27	-	0.17	-	-
Change in Receivables	0.06	-	0.14	-	-
Changes in Inventories	-0.02	-	0.23	-	-
Changes in Accrued Expenses	-0	-1.81	-0.05	0.3	2.58
Changes in Income Taxes Payable	-0.06	-	0	-	-
Changes in Other Operating Activities	0.23	4.44	-0.26	4.64	-3.74
Operating Cash Flow	0.39	-7.99	0.06	-16.11	-20.83
Capital Expenditures	-0	-	-0	-0.01	-0.01
Investing Cash Flow	-0	-	-0	-0.01	-0.01
Long-Term Debt Issued	-0.07	-	0.02	-	-
Net Long-Term Debt Issued (Repaid)	-0.07	-	0.02	-	-
Issuance of Common Stock	-	7.82	-	1.05	3.2
Net Common Stock Issued (Repurchased)	-	7.82	-	1.05	3.2
Preferred Share Dividends Paid	-	-	-	-0.2	-0.2
Financing Cash Flow	-0.07	7.82	0.02	0.85	3
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.02	-0.07	-0.01	0.3	-0.38
Net Cash Flow	0.34	-0.24	0.06	-14.97	-18.21
Free Cash Flow	0.39	-7.99	0.06	-16.12	-20.83
FCF Margin	20.41%	-9290.70%	2.80%	-1918.81%	-
Free Cash Flow Per Share	0.13	-19.11	0.02	-4546.60	-444.23
Levered Free Cash Flow	-0.02	-8.58	-0.2	-17.79	-22.54
Unlevered Free Cash Flow	-0.02	-8.59	-0.27	-17.5	-23.76

Updated Aug 14, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.